YOKNEAM ILIT, Israel, Oct. 5, 2020 /PRNewswire/ — PixCell Medical, innovator of rapid diagnostic solutions at the
point-of-care, announced today that it has received regulatory approval from the Australian Therapeutic Goods Administration (TGA) for the HemoScreen, PixCell’s hematology analyzer that offers a
5-part differential CBC intended for point-of-care (POC) use. Under the TGA approval,